Drug intelligence / Profile preview

DNAmix

Development stage
Unknown
Lead developer
Vaxxinova
Modality
Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intramuscular
01

Overview

DNAmix is a veterinary DNA vaccine developed by Vaxxinova for the aquaculture industry, specifically for the protection of Atlantic salmon (*Salmo salar*) against Salmon Pancreas Disease (SPD) and Salmon Rickettsial Septicaemia (SRS). The vaccine utilizes a DNA plasmid platform to deliver genetic sequences encoding specific viral or bacterial antigens—such as the structural proteins of Salmonid Alphavirus (SAV) or antigens from *Piscirickettsia salmonis*. Upon intramuscular injection, the host's myocytes take up the plasmids and express the encoded proteins, which are then presented to the immune system to elicit both cell-mediated and humoral immunity. This technology offers a significant advantage over traditional oil-adjuvanted vaccines by reducing internal organ adhesions and melanosis while providing robust, long-term protection.

Brand names
DNAmix
Other names
DNA-mix
02

Targets

SAV (Salmonid alphavirus)Piscirickettsia salmonis

Beyond the preview

Go deeper on DNAmix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNAmix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call